Sofinnova is a clinical-stage biopharmaceutical venture capital firm with $1.6B under management. We are a passionate and committed team of MDs and PhDs that deploy human and financial capital to improve the lives of patients through science. Our mission is to provide industry leading venture returns by delivering transformative medicines to patients.
People
- James Healy, General Partner
You last contacted this investor on .